Cells within the synovial tissue may recruit mononuclear phagocytes into the synovial fluid and tissues of arthritic patients. We investigated the production of the chemotactic cytokine monocyte chemoattractant protein-i (MCP-1) using sera, synovial fluid, synovial tissue, as well as macrophages and fibroblasts isolated from synovial tissues from 80 arthritic patients. MCP-1 levels were significantly higher (P < 0.05) in synovial fluid from RA patients (mean 25.5±8.1 ng/ml ISEI) compared to synovial fluid from osteoarthritis (OA) patients (0.92±0.08), or from patients with other arthritides (2.9±1.5). MCP-1 levels in RA sera (8.44±2.33) were significantly greater than MCP-1 in normal sera (0.16±0.06). The quantities ofRA synovial fluid IL-8, which is chemotactic for neutrophils and lymphocytes, and MCP-1 were strongly positively correlated (P < 0.05). To examine the cellular source of MCP-1, RA synovial tissue macrophages and fibroblasts were isolated. Synovial tissue fibroblasts did not express MCP-1 mRNA, but could be induced to produce MCP-1 by stimulation with either IL-1#, tumor necrosis factor-alpha (TNF-a), or LPS. In contrast, unlike normal peripheral blood monocytes or alveolar macrophages, RA synovial tissue macrophages constitutively expressed MCP-1 mRNA and antigen. Immunohistochemical analysis of synovial tissue showed that a significantly greater percentage of RA macrophages (50±8%) as compared to either OA macrophages (5±2) or normal macrophages (1±0.3) reacted with anti-MCP-1 antibodies. In addition, the synovial lining layer reacted with MCP-1 in both RA and OA synovial tissues. In contrast, only a minority of synovial fibroblasts (18±8%) from RA synovium were positive for immunolocalization of MCP-1. These results suggest that synovial production of MCP-1 may play an important role in the recruitment of mononuclear phagocytes during inflammation associated with RA and that synovial tissue macrophages are the dominant source of this cytokine. (J. Clin. Invest. 1992. 90:772-779.) 
Introduction
Synovial tissue macrophages are important in mediating RA joint destruction, mainly due to their ability to process antigen stimulating factor-I and granulocyte-macrophage colony-stimulating factor (GM-CSF) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . In addition, macrophages mediate the fibroproliferative phase ofRA by producing angiogenic activity (16, 17) . Furthermore, synovial macrophages may influence synovial fibroblasts to liberate the cytokines IL-6, -8, and GM-CSF, via TNF-a and IL-1, thus creating an operative cytokine network in the joint.
The mechanism by which synovial monocytes are recruited into synovial tissues and fluids has not been fully elucidated. Synovial tissue blood vessel endothelial cells express adhesion molecules like vascular cell adhesion molecule-I, which can mediate the binding of monocytes to blood vessels ( 18, 19) . In addition, it is likely that chemoattractants released by cells in the synovial tissue and fluid recruit mononuclear phagocytes into the joint.
Recently a chemotactic cytokine, termed monocyte chemoattractant protein-I (MCP-1) has been identified (20) (21) (22) (23) . This chemotaxin is expressed by a variety of cell types, including leukocytes, smooth muscle cells, endothelial cells, fibroblasts, epithelial cells, and tumor cell lines (20, (24) (25) (26) (27) (28) (29) (30) (31) (32) . Moreover, this cytokine appears to have selective chemotactic activity for mononuclear phagocytes. The role of this cytokine in the inflamed RA joint has, as yet, not been defined.
In this study, we demonstrated significantly greater MCP-1 levels from synovial fluids of patients with RA as compared with osteoarthritis (OA) or other inflammatory and noninflammatory arthritides. Patients with RA had increased levels of MCP-1 in their serum as compared to normal volunteers. Furthermore, levels of MCP-1 and another chemotaxin, IL-8, were strongly and positively correlated from synovial fluids and sera of RA patients. Isolated Isolation ofhuman RA synovial tissuefibroblasts and macrophages and preparation of conditioned media. Fresh synovial tissues were minced and digested in a solution of dispase, collagenase, and DNase, as previously described (16) (17) (18) 34) . Synovial fibroblast cells were cultured in RPMI plus 10% FCS containing 1 mM glutamine, 25 mM Hepes,100 U/ml penicillin, l00 ng/ml streptomycin (Gibco Laboratories, Grand Island, NY), and 1% nonessential amino acids (complete media) in 75-mm tissue culture flasks (Costar Corp., Cambridge, MA). Upon reaching confluence, the cells were passaged by brief trypsinization as previously described (16) . The cells were used at passage 4 or older, at which time they were a homogenous population offibroblastic cells. The cells were plated at a concentration of 8.8 X I04 cells/well in 24-well plates (Costar Corp.) in I ml serum-free RPMI. Various concentrations of IL-1/, TNF-a, or LPS in RPMI were added, and conditioned media harvested.
For isolation of synovial tissue macrophages, the tissues were minced and digested as described above. The resultant single-cell suspensions were fractionated into density-defined subpopulations by isopyknic centrifugation through continuous preformed Percoll gradients (Pharmacia Inc., Piscataway, NJ). Macrophages were enriched by adherence to fibronectin-coated collagen gels and selective trypsinization (incubation with trypsin:EDTA for 5-10 min) (16, 17, 34, 35) . Macrophages were harvested from the collagen gels by treatment with clostridial collagenase and found to be 2 90% pure, as assessed by Fc receptormediated phagocytosis of IgG opsonized sheep red blood cells, esterase staining, and staining with commercial antimacrophage mAbs (16, 17) . For preparation of conditioned medium, freshly isolated macrophages were incubated in DME + gentamicin at 1 x 106 cells/ml, and supernatants collected after 24 h.
MCP-I ELISA. Antigenic MCP-I was measured using a modification of a double ligand method as previously described (36) . In brief, 96-well plates (Nunc, Kamstrup, Denmark) were coated with 50 i1/ well rabbit anti-MCP-1 (3.2 Mig/ ml in 0.6 M NaCl, 0.26 M H3BO4, and 0.08 N NaOH, pH 9.6) for 16 h at 4°C and then washed in PBS, pH 7.5, 0.05% Tween-20 (wash buffer). Nonspecific binding sites were blocked with 2% BSA in PBS (200 /l), and the plates incubated for 90 min at 37°C. Plates were rinsed (3x) with wash buffer and diluted (neat, 1:5, and 1:10) test sample (50 Id) in duplicate was added, followed by incubation for 1 h at 37°C. Plates were washed (4x) and 50 ,Ml/well biotinylated rabbit anti-MCP-1 (6 vg/ml in PBS, pH 7.5, 0.05% Tween-20, 2% FCS) added for 45 min at 37°C. Plates were washed (4x), streptavidin-peroxidase conjugate (100 ,ug/ml) (Dako patts) added, and the plates were incubated for 30 min at 37°C. The plates were washed (3x ) and 100I l chromogen substrate (0.67 mg/ml orthophenylenediamine dichloride) (Dako patts) added. The plates were incubated at 25°C for 6 min, and the reaction terminated with 50 dl/well of 3 M H2SO4 solution in wash buffer plus 2% FCS. Plates were read at 490 nm in an ELISA reader. Standards were 1/2 log dilutions of recombinant MCP-1 from 1,000 ng/ml to 1 pg/ml (50 Ml/well). The ELISA consistently detected MCP-1 concentrations > 0.05 ng/ml. IL-8 ELISA. Antigenic IL-8 was measured using a modification of a double ligand method as previously described using polyclonal anti-IL-8 (1). The assay was standardized using human recombinant IL-8.
Northern blot analysis. Total cellular RNA was obtained from 2.5 x 106 macrophages or confluent fibroblasts in 100-mm tissue culture dishes using a modification of Chirgwin et al. and Jonas et al. (37) (38) (39) . Briefly, cells were scraped into a solution containing 25 mM Tris, pH 8.0, 4.2 M guanidine isothiocyanate, 0.5% Sarkosyl, and 0.1 M 2-mercaptoethanol. After homogenization, the suspension was added to a solution containing an equal volume of 100 mM Tris, pH 8.0, 10 mM EDTA, and 1% SDS. The mixture was then extracted with chloroformphenol and chloroform-isoamyl alcohol. The RNA was alcohol precipitated and the pellet dissolved in diethylpyrocarbonate-treated H20. Total RNA was separated by Northern analysis using formaldehyde, 1% agarose gels, transblotted onto nitrocellulose, baked, prehybridized, and hybridized with a 32P-5' end-labeled oligonucleotide probe. A 30-mer oligonucleotide probe was synthesized using the published cDNA sequence for human-derived MCP-1 (20) . The probe was complementary to nucleotides 256-285 and had the sequence 5'-TTG-GGT-TTG-CTT-GTC-CAG-GTG-GTC-CAT-GGA-3'. Blots were washed and autoradiographs were quantitated using laser densitometry (Ultrascan XS; LXB Instruments, Inc., Houston, TX). Equivalent amounts of total RNA/gel were assessed by monitoring 28s and 18s rRNA.
Bioassay for chemotactic activity for monocytes. Chemotaxis of monocytes was performed as previously described (24) . Normal human mononuclear cells were obtained from peripheral blood by FicollHypaque density gradient centrifugation. Monocytes were suspended in HBSS with calcium and magnesium (Gibco Laboratories) at 3 x 106 cells/ ml with > 95% viability by trypan blue exclusion. In brief, 150 Al of synovial fluid or synovial tissue macrophage conditioned medium which was diluted 1:1 with HBSS, 10-8 M FMLP (Sigma Chemical Co.), or HBSS alone were placed in duplicate bottom wells of a blindwell chemotaxis chamber. A 5-,um pore size polyvinylpyrrolidone-free polycarbonate filter (Nuclepore Corp., Pleasanton, CA) was placed in the assembly and 250 ul of monocyte suspension placed in each of the top wells. Chemotaxis chambers were incubated at 37°C in humidified 95% air/ 5% CO2 for 2 h. The filters were removed, fixed in absolute methanol, and stained with 2% toluidine blue (Sigma Chemical Co.). Monocytes that had migrated through to the bottom of the filter were counted in 10 high power fields ( x 1,000).
Immunoperoxidase staining. 4-tm sections of frozen tissues were cut, and immunoperoxidase stained using an avidin-biotin technique (Vector Laboratories, Burlingame, CA) (34, (40) (41) (42) (43) (44) . Slides, air dried for 2-16 h, were fixed in cold acetone for 20 min. Endogenous peroxidase activity was quenched by incubating the slides for 30 min in 0.3% hydrogen peroxide in methanol. All subsequent incubations were performed for 15 min at 37°C in a moist chamber. The tissue sections were pretreated with 50 M1 diluted normal horse serum ( 135 Ml horse serum in 10 ml 1% PBS-BSA), incubated with either rabbit anti-human MCP-1, preimmune rabbit serum, mAb Leu-M5, mAb HAM56, or control mAb and washed (2x). The slides were incubated with a 1:400 dilution of anti-mouse biotinylated antibody in PBS-BSA, washed (2x) with PBS, incubated with avidin/biotinylated horseradish peroxidase complex, and washed with PBS (2x). Slides were then stained with diaminobenzidine tetrahydrochloride substrate for 5 min at room temperature, rinsed in tap water for 2 min, counterstained with Harris' hematoxylin, and dipped in saturated lithium carbonate solution for bluing. Serial tissue sections were examined to determine the percentage of each cell type expressing antigenic MCP-I ( 18, 34, 43) .
Cytospin preparations of isolated RA synovial tissue macrophages were made using 105 cells per slide in a cytospin (Shandon I; Shandon Inc., Swickley, PA). Slides were stained using immunohistochemistry as described above.
Statistical analysis. Statiscal analysis was performed using analysis of variance (45, 46). P values < 0.05 were considered significant. Results MCP-J is elevated in both RA synovialfluid and sera. In initial experiments, MCP-1 was measured by ELISA using samples obtained from 27 patients (Fig. 1) . The patients with RA had the greatest levels of MCP-1 (mean 25.5±8.1 ng/ml). OA patients as compared with RA patients had significantly less MCP-l in their synovial fluids (0.92±0.08 ng/ml, P < 0.05). Patients with other forms of inflammatory and noninflammatory arthritis including polymyositis, Reiter's syndrome, chronic lymphocytic leukemia, and mixed connective tissue disease had a mean of 2.9±1.5 ng/ml of synovial fluid MCP-1, which was also significantly less than patients with RA (P < 0.05).
To determine whether peripheral blood from patients with RA also contained significant quantities of MCP-1 compared to normal volunteers, serum MCP-1 levels were determined by ELISA using 19 RA samples (Fig. 1) . Serum levels of RA MCP-1 ranged from <0.08 ng/ml to 179.2 ng/ml (mean 22.4±8.9). In contrast normal sera obtained from 10 volun- teers contained significantly less MCP-1 (< 0.05 to 0.72 ng/ ml) (mean 0.16±0.06, P < 0.05). The high levels of MCP-1 present in the RA sera were not attributable to rheumatoid factor in these samples, since there was no correlation between rheumatoid factor positivity (using rabbit IgG) and MCP-1 levels.
Positive correlation between synovial fluid and serum MCP-I and IL-8 levels. Since cells ofthe synovial milieu might concomitantly recruit both monocytes and other inflammatory leukocytes, we wished to determine whether those patients who produced large quantities of MCP-1 also produced large quantities of IL-8. ELISA assays were performed on the sera and synovial fluids of arthritic patients to determine the quantities of IL-8 produced. Comparing RA synovial fluid MCP-1 and IL-8 levels, a significant positive correlation (r = 0.57, P -18s A < 0.05) was found. Similarly, synovial fluid from other arthritides contained MCP-1 and IL-8 levels which were also strongly positively correlated (r = 0.96, P < 0.05). RA serum MCP-1 and IL-8 levels were correlated, implying a parallel relationship between the amounts of chemotactic cytokines released specific for differing leukocyte populations in this disorder (Fig. 2, r was absent in nonstimulated RA fibroblasts, but readily inducible upon LPS (1l g/ml), IL-tlo (20 ng/ml), or TNF-a (20 ng/ml) treatment of cells (Fig. 4) .
RA synovial fluid and macrophage generated monocyte chemotactic activity. We then determined whether RA synovial fluids and conditioned medium from synovial tissue macrophages produced biologically active chemotactic activity for monocytes. Chemotactic activity for normal human peripheral blood monocytes was detected in the RA synovial fluids examined (Table I) . Conditioned medium from nonstimulated macrophages obtained from six patients also contained chemotactic activity for monocytes. Measurable antigenic MCP-1 ranged from < 0.05 to 7.4 ng/ml in these samples. The amounts of chemotactic activity for monocytes and antigenic MCP-1 did not correlate, implying the presence of additional chemotactic factors for monocytes in the synovial fluids and in the RA synovial tissue macrophage supernatants.
Synovial tissue macrophage production ofMCP-1. To determine if RA synovial tissue macrophages constitutively expressed MCP-1, MCP-1 gene expression was determined using isolated RA synovial tissue macrophages (Fig. 5) . In contrast to RA fibroblasts, RA macrophages did not require exogenous stimulation to express MCP-1 mRNA. To confirm macrophage constitutive MCP-1 production, macrophages were freshly isolated from the synovial tissues of RA patients, cytospun, and stained for immunolocalization of MCP-1. (Fig. 7 A) and 60±10% of the OA lining cells (Fig. 7 B) , but only to 1±0.3% of the lining cells found in normal synovial tissues (Fig. 7 D) (P < 0.05 for either RA or OA compared to normal). RA synovial tissue macrophages located in the subsynovial areas also expressed MCP-1, with 50±8% of macrophages being MCP-1 positive (Fig. 7 C) . In contrast, only 5±2% of the OA Leu-M5 positive macrophages were MCP-1 positive (P < 0.05) (Fig. 7) . Similarly, RA macrophage antigenic MCP-1 expression was significantly greater than the expression found in normal synovial tissues (P <0.05).
As compared to the reactivity ofthe majority of RA macrophages with anti-MCP-1, MCP-1 expression was found in a minority of fibroblasts from both RA (mean of 18±8%) and OA (mean of 9±3%). In addition, a small percentage (mean 9.4±6.3%) of synovial tissue blood vessel smooth muscle cells were MCP-1 positive. Discussion MCP-1 is a 76-amino acid basic protein with selective chemotactic activity for mononuclear phagocytes (23, 47) . MCP-1 exists in two forms: MCP-1 a, with a mol wt of 13,000, and MCP-1 3, with a mol wt of 15,000 (20, 47) . These two forms of MCP-1 are functionally identical, differing only by the extent of posttranslational modification. MCP-1 belongs to a supergene family that includes LD78, ACT-2, RANTES, and 1-309 (48) .
The role of MCP-1 in the inflamed RA joint may be the recruitment of mononuclear phagocytes. There are a variety of chemotactic factors which may attract mononuclear phagocytes in the RA joint. These include thrombin, C5a, platelet CU activating factor, leukotriene B4, lymphocyte-derived chemotactic factor, and the cytokines transforming growth factorbeta, GM-CSF, and platelet-derived growth factor (PDGF) (49, 50) . In this study, we demonstrated that the cytokine MCP-1 may also serve as a potent stimulus for recruitment of mononuclear phagocytes in RA.
We examined synovial fluids from patients with various arthritides for MCP-1. MCP-1 levels were significantly elevated in synovial fluids from patients with RA as compared to OA or other arthritides. Moreover, while the serum levels of MCP-1 were 0.16±0.06 ng/ml from normal subjects, MCP-1 RA serum levels were significantly increased (22.4±8.9 ng/ml, P < 0.05).
The process of synovial inflammation likely results from the influx ofa series ofinflammatory cells that release a cascade of inflammatory mediators. We reasoned that synovial fluids and sera containing chemotactic factors for mononuclear phagocytes such as MCP-1 might also contain chemotactic factors for neutrophils and lymphocytes. Indeed, we found a strong positive correlation between MCP-1 and IL-8 in both synovial fluid and serum of patients with RA. These results suggested that the same factors which might upregulate production of MCP-1 also influence the production of IL-8 (1). Hence, we examined whether RA fibroblasts produced MCP-1 in response to the same agonists which upregulated production of synovial fibroblast IL-8. As described by DeMarco et al., who showed that RA synovial fibroblasts expressed MCP-1 mRNA in response to IL-1 and TNF-a, we demonstrated that RA fibroblasts respond to these signals as well as to LPS and produce both MCP-1 mRNA and protein (5 1 ). While RA fibroblasts spontaneously produced either nondetectable or low levels of MCP-I, TNF-a, or IL-13f, and to a lesser extent LPS induced increased levels offibroblast MCP-1. These same stimuli serve as inducing agents for RA fibroblast IL-8 production. It is likely that in the inflamed RA synovium, macrophages produce IL-1 and TNF-a, both of which act on synovial fibroblasts to stimulate release of IL-8 and MCP-1, which in turn selectively recruit neutrophils, lymphocytes, and mononuclear phagocytes into the joint.
While (52) . Perhaps, in the inflamed synovial milieu the synovial macrophage assumes a phenotype of chronic activation with subsequent inflammatory cytokine release. Indeed, MCP-1 has been shown to "activate" monocytes, causing cytostatic activity against tumor cell lines, stimulation of the leukocyte respiratory burst, and lysosomal enzyme release (23, 47 
